{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:50:59Z","timestamp":1791481859900,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00951-x","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:31:10Z","timestamp":1791433870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computer-aided molecular engineering of novel imidazolone\u2013chalcone conjugates as antidiabetic agent: synthesis, molecular docking, DFT study, enzyme kinetics and ADME profiling"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3517-8853","authenticated-orcid":false,"given":"Tayyiaba","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampath","family":"Chinnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masi A.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhi M.","family":"Gomha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E. A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khasan","family":"Kayumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania H.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faoz H.","family":"Al-Atawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"951_CR1","unstructured":"D. Atlas, International diabetes federation, IDF Diabetes Atlas, 7th Edn. Brussels, Belgium Int. Diabetes Fed. 33 (2015)."},{"key":"951_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.beem.2016.05.003","volume":"30","author":"LM Jaacks","year":"2016","unstructured":"Jaacks LM, Siegel KR, Gujral UP, Narayan KMV (2016) Type 2 diabetes: a 21st century epidemic. Best Pract Res Clin Endocrinol Metab 30:331\u2013343","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"951_CR3","first-page":"265","volume":"26","author":"H Gin","year":"2000","unstructured":"Gin H, Rigalleau V (2000) Post-prandial hyperglycemia. post-prandial hyperglycemia and diabetes. Diabetes Metab 26:265\u2013272","journal-title":"Diabetes Metab"},{"key":"951_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2003.12.031","volume":"92","author":"WL Li","year":"2004","unstructured":"Li WL, Zheng HC, Bukuru J, De Kimpe N (2004) Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92:1\u201321","journal-title":"J Ethnopharmacol"},{"key":"951_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M (2020) Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect 10:98","journal-title":"Health Promot Perspect"},{"key":"951_CR6","first-page":"1","volume":"7","author":"G Bereda","year":"2021","unstructured":"Bereda G, Bereda G (2021) The incidence and predictors of poor glycemic control among adults with type 2 diabetes mellitus in ambulatory clinic of Mettu Karl referral hospital, south western, Ethiopia: a prospective cross sectional study. Int Arch Endocrinol Clin Res 7:1\u201322","journal-title":"Int Arch Endocrinol Clin Res"},{"key":"951_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311\u2013321","journal-title":"Diabetes Res Clin Pract"},{"key":"951_CR8","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.foodchem.2013.04.123","volume":"141","author":"S Lordan","year":"2013","unstructured":"Lordan S, Smyth TJ, Soler-Vila A, Stanton C, Ross RP (2013) The \u03b1-amylase and \u03b1-glucosidase inhibitory effects of Irish seaweed extracts. Food Chem 141:2170\u20132176","journal-title":"Food Chem"},{"key":"951_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0889-8529(05)70266-8","volume":"26","author":"HE Lebovitz","year":"1997","unstructured":"Lebovitz HE (1997) Alpha-glucosidase inhibitors. Endocrinol Metab Clin North Am 26:539\u2013551","journal-title":"Endocrinol Metab Clin North Am"},{"key":"951_CR10","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2147\/VHRM.S3119","volume":"4","author":"FA Van de Laar","year":"2008","unstructured":"Van de Laar FA (2008) Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc Health Risk Manag 4:1189\u20131195","journal-title":"Vasc Health Risk Manag"},{"key":"951_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1517\/14728222.2012.664134","volume":"16","author":"U Etxeberria","year":"2012","unstructured":"Etxeberria U, de la Garza AL, Campi\u00f3n J, Mart\u00ednez JA, Milagro FI (2012) Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase. Expert Opin Ther Targets 16:269\u2013297","journal-title":"Expert Opin Ther Targets"},{"key":"951_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-018-5637-9","volume":"18","author":"JA da Silva","year":"2018","unstructured":"da Silva JA, de Souza ECF, Echaz\u00fa B\u00f6schemeier AG, da Costa CCM, Bezerra HS, Feitosa EELC (2018) Diagnosis of diabetes mellitus and living with a chronic condition: participatory study. BMC Public Health 18:1\u20138","journal-title":"BMC Public Health"},{"key":"951_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2022.100606","volume":"4","author":"E Kabir","year":"2022","unstructured":"Kabir E, Uzzaman M (2022) A review on biological and medicinal impact of heterocyclic compounds. Results Chem 4:100606","journal-title":"Results Chem"},{"key":"951_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1877946813666221021144829","volume":"13","author":"J Baranwal","year":"2023","unstructured":"Baranwal J, Kushwaha S, Singh S, Jyoti A (2023) A review on the synthesis and pharmacological activity of heterocyclic compounds. Curr Phys Chem 13:2\u201319","journal-title":"Curr Phys Chem"},{"key":"951_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2174\/1381612826666200206093815","volume":"26","author":"M Fesatidou","year":"2020","unstructured":"Fesatidou M, Petrou A, Athina G (2020) Heterocycle compounds with antimicrobial activity. Curr Pharm Des 26:867\u2013904","journal-title":"Curr Pharm Des"},{"key":"951_CR16","first-page":"10","volume":"13","author":"LP Singh","year":"2022","unstructured":"Singh LP (2022) A review of heterocyclic compounds for anti-diabetic activity. Syst Rev Pharm 13:10\u201331858","journal-title":"Syst Rev Pharm"},{"key":"951_CR17","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.2174\/1871520622666220404082648","volume":"22","author":"N Kumar","year":"2022","unstructured":"Kumar N, Goel N (2022) Heterocyclic compounds: importance in anticancer drug discovery. Anti-Cancer Agents Med Chem 22:3196\u20133207","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"951_CR18","first-page":"945","volume":"1","author":"SG Gaybullayevna","year":"2022","unstructured":"Gaybullayevna SG (2022) Synthesis of drugs from nitrogen heterocyclic compounds. Ho\u0432oc\u0442\u0438 O\u0431pa\u0437o\u0432a\u043d\u0438\u044f \u0418cc\u043be\u0434o\u0432a\u043d\u0438e \u0432 XXI Be\u043ae 1:945\u2013955","journal-title":"Ho\u0432oc\u0442\u0438 O\u0431pa\u0437o\u0432a\u043d\u0438\u044f \u0418cc\u043be\u0434o\u0432a\u043d\u0438e \u0432 XXI Be\u043ae"},{"key":"951_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12111618","volume":"12","author":"K Witek","year":"2023","unstructured":"Witek K, Kaczor A, \u017bes\u0142awska E, Podlewska S, Mar\u0107 MA, Czarnota-\u0141ydka K, Nitek W, Latacz G, Tejchman W, Bischoff M (2023) Chalcogen-varied imidazolone derivatives as antibiotic resistance breakers in Staphylococcus aureus strains. Antibiotics (Basel) 12:1618","journal-title":"Antibiotics (Basel)"},{"key":"951_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jhet.588","volume":"48","author":"NB Patel","year":"2011","unstructured":"Patel NB, Patel HR (2011) Design and synthesis of new imidazolinone derivatives as potential antifungal agents. J Heterocycl Chem 48:373\u2013380","journal-title":"J Heterocycl Chem"},{"key":"951_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107471","volume":"149","author":"YS Sheta","year":"2024","unstructured":"Sheta YS, Sarg MT, Abdulrahman FG, Nossier ES, Husseiny EM (2024) Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: design, synthesis, cytotoxicity evaluation, and mechanistic insights. Bioorg Chem 149:107471","journal-title":"Bioorg Chem"},{"key":"951_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102023","volume":"34","author":"A Husain","year":"2022","unstructured":"Husain A, AlAsmari AF, Azmi SNH, Ali N, Sarker MMR, Alharbi M, Ishtikhar M, Khan SA (2022) Rational drug design, synthesis, and in vivo biological activity of new indolyl-imidazolone hybrids as potential and safer non-steroidal anti-inflammatory agents. J King Saud Univ 34:102023","journal-title":"J King Saud Univ"},{"key":"951_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bioorg.2017.04.002","volume":"72","author":"KRA Abdellatif","year":"2017","unstructured":"Abdellatif KRA, Fadaly WAA (2017) New 1, 2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents. Bioorg Chem 72:123\u2013129","journal-title":"Bioorg Chem"},{"key":"951_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1573409914666180516113552","volume":"14","author":"IH Khan","year":"2018","unstructured":"Khan IH, Patel NB, Patel VM (2018) Synthesis, in silico molecular docking and pharmacokinetic studies, in vitro antimycobacterial and antimicrobial studies of new imidozolones clubbed with thiazolidinedione. Curr Comput Aided Drug Des 14:269\u2013283","journal-title":"Curr Comput Aided Drug Des"},{"key":"951_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/14756366.2011.584191","volume":"27","author":"NS Hari Narayana Moorthy","year":"2012","unstructured":"Hari Narayana Moorthy NS, Saxena V, Karthikeyan C, Trivedi P (2012) Synthesis, in silico metabolic and toxicity prediction of some novel imidazolinones derivatives as potent anticonvulsant agents. J Enzyme Inhib Med Chem 27:201\u2013207","journal-title":"J Enzyme Inhib Med Chem"},{"key":"951_CR26","doi-asserted-by":"publisher","first-page":"9368","DOI":"10.1021\/acsomega.4c10095","volume":"10","author":"BSK Aktar","year":"2025","unstructured":"Aktar BSK, S\u0131cak Y, Bak\u0131rd\u00f6ven A, Y\u0131lmaz GT, Y\u0131lmaz O, Karakucuk-Iyidogan A, Tasdemir D, Saglam E, Oru\u00e7-Emre EE (2025) Discovery of novel pyrrolidine-based chalcones as dual inhibitors of \u03b1-amylase and \u03b1-glucosidase: synthesis, molecular docking, ADMET profiles, and pharmacological screening. ACS Omega 10:9368\u20139380","journal-title":"ACS Omega"},{"key":"951_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.comptc.2025.115218","volume":"1248","author":"I Shafiq","year":"2025","unstructured":"Shafiq I, Fatima N, Arshad M, Tariq A, Amir L, Bullo S, Alrashidi KA (2025) Exploring the influence of end capped acceptor modification on photovoltaic properties of 1, 4-dihydropyridine based functionalized materials: DFT\/TD-DFT study. Comput Theor Chem 1248:115218","journal-title":"Comput Theor Chem"},{"issue":"14","key":"951_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30143009","volume":"30","author":"M Nov\u00e1s","year":"2025","unstructured":"Nov\u00e1s M, Matos MJ (2025) The role of trifluoromethyl and trifluoromethoxy groups in medicinal chemistry: implications for drug design. Molecules 30(14):3009","journal-title":"Molecules"},{"issue":"9","key":"951_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ph18091333","volume":"18","author":"MM Khowdiary","year":"2025","unstructured":"Khowdiary MM, Felemban S (2025) Fused imidazotriazole-based therapeutics: a multidisciplinary study against diabetes-linked enzymes alpha-amylase and alpha-glucosidase using in vitro and in silico methods. Pharmaceuticals (Basel) 18(9):1333","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"951_CR30","doi-asserted-by":"publisher","first-page":"8113","DOI":"10.1021\/acscatal.5c09283","volume":"16","author":"ZZ Shi","year":"2026","unstructured":"Shi ZZ, Zhou RY, Wang YH, Zheng S, Li JF (2026) Geometry-enabled hydrogen bonding alignment dictates CO2 electroreduction kinetics on gold facets. ACS Catal 16(9):8113\u20138121","journal-title":"ACS Catal"},{"key":"951_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fuel.2025.135753","volume":"400","author":"X Qiu","year":"2025","unstructured":"Qiu X, Cao X, Zhang F, Xiao M, Huang T, Zhu Q, Shang Z, Song H (2025) Unraveling the intermolecular interaction profiles of poly (ionic liquid) s with phenolic compounds: insights into aromaticity, stacking, and bonding. Fuel 400:135753","journal-title":"Fuel"},{"issue":"8","key":"951_CR32","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1021\/acs.chemrev.4c00868","volume":"125","author":"H Hyrondelle","year":"2025","unstructured":"Hyrondelle H, Terry A, Lhoste J, Tenc\u00e9 S, Lemoine K, Olchowka J, Dambournet D, Tassel C, Gamon J, Demourgues A (2025) Fluorine as a key element in solid-state chemistry of mixed anions 3d transition metal-based materials for electronic properties and energy. Chem Rev 125(8):4287\u20134358","journal-title":"Chem Rev"},{"issue":"1","key":"951_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-026-00845-y","volume":"40","author":"MU Naeem","year":"2026","unstructured":"Naeem MU, Khursheed F, Aslam S, Khan Y, Ishaq W, Akif M, Sattar A, Faheem M, Hawsawi MB, Rehman W (2026) Computer-aided design, molecular dynamics simulations and in-vitro inhibitory potential of piperazine bridged bis-thiadiazole benzothioate derivatives against platelet-derived endothelial cell growth factor. J Comput Aided Mol Des 40(1):156","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"951_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/17568919.2025.2525066","volume":"17","author":"S Khan","year":"2025","unstructured":"Khan S, Iqbal T, Hussain R, Fiaz Z, Abdellattif MH, Kashtoh H (2025) Novel thiazole\u2013thiadiazole as a potential anti-Alzheimer agent: synthesis and molecular interactions via an in silico study. Future Med Chem 17(12):1349\u20131361","journal-title":"Future Med Chem"},{"key":"951_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2026.1867973","volume":"14","author":"R Ai","year":"2026","unstructured":"Ai R, Muhammad N, Cui Y, Wang L, Wang Y, Weng S, Kakar MU, Khan S, Ahmad S (2026) Biocatalytic reduction of nitro-sulfonamides: enzyme engineering, process integration, and sustainable pathways to p-aminobenzenesulfonamide. Front Bioeng Biotechnol 14:1867973","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"951_CR36","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1039\/D5SC07348K","volume":"17","author":"CJ Summerfield","year":"2026","unstructured":"Summerfield CJ, Pattison G (2026) Which halogen to choose? Comparing the effects of chlorine and fluorine as bioisosteric substituents in drug design. Chem Sci 17(5):2477\u20132505","journal-title":"Chem Sci"},{"key":"951_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S2737416526501103","volume":"18","author":"MN Tahir","year":"2026","unstructured":"Tahir MN, Ashfaq M, Munawar KS, Andleeb S, Shafiq I, Manzoor MT, Raza N, Shaheen A, Smerat A (2026) Synthesis, SC-XRD, Key Electronic Properties of Nitro-Containing Schiff Base Chromophores: An Experimental and Computational Study. J Comput Biophys Chem 18:1\u20137","journal-title":"J Comput Biophys Chem"},{"key":"951_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.comptc.2025.115465","author":"W Su","year":"2025","unstructured":"Su W, Jiang Z, Khan A, Usman R, Wang M (2025) Charge-transfer cocrystal engineering of anthracene chalcone compound containing cyano group: DFT-guided modulation of solid-state optical properties. Comput Theor Chem. https:\/\/doi.org\/10.1016\/j.comptc.2025.115465","journal-title":"Comput Theor Chem"},{"issue":"4","key":"951_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1039\/D4ME00135D","volume":"10","author":"KK Harish","year":"2025","unstructured":"Harish KK, Khamees HA, Venkatesha K, Nagaraja O, Madegowda M (2025) The pivotal role of the carbonyl group in methoxy chalcones: comprehensive analyses of the structure and computational insights into binding affinity towards monoamine oxidase enzymes. Mol Syst Des Eng 10(4):236\u2013263","journal-title":"Mol Syst Des Eng"},{"key":"951_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2026.108920","author":"Z Fiaz","year":"2026","unstructured":"Fiaz Z, Khan S, Iqbal T, Rehman W, Fareed A, Hussain R, Ogli KK, Khan M, Shaik MR (2026) Tailored pyrrole-based imidazothiazole scaffolds: synthetic elaboration, enzyme kinetic profiling and DFT-guided molecular docking toward antidiabetic therapeutics. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.108920","journal-title":"Comput Biol Chem"},{"key":"951_CR41","first-page":"1","volume":"17","author":"S Muhammad","year":"2026","unstructured":"Muhammad S, Latif A, Alam A, Ali M, Elhenawy AA, Ahmad M, Ahmad S, Ali Shah SA, Imran S, Ali KF (2026) Synthesis of polyhydroquinoline derivatives as potent antidiabetic and antioxidant agents: in vitro biological activities and computational studies. Future Med Chem 17:1\u201322","journal-title":"Future Med Chem"},{"issue":"8","key":"951_CR42","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1080\/10406638.2025.2478141","volume":"45","author":"M Ayaz","year":"2025","unstructured":"Ayaz M, Alam A, Zainab URN, Elhenawy AA, Kamal M, Lodhi MA, Ali M, Latif A, Al-Harrasi A, Ahmad M (2025) Synthesis, tyrosinase inhibition, molecular docking, and DFT studies of amide derivatives of fexofenadine. Polycyc Aroma Compd 45(8):1600\u201326","journal-title":"Polycyc Aroma Compd"},{"key":"951_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.142261","volume":"1338","author":"S Khan","year":"2025","unstructured":"Khan S, Iqbal T (2025) A new synthetic approach for determination of thiadiazole clubbed sulfonamide as diabetic therapeutic with in silico modeling and kinetic study. J Mol Struct 1338:142261","journal-title":"J Mol Struct"},{"key":"951_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148369","author":"S Khan","year":"2025","unstructured":"Khan S, Iqbal T, Abass KS, Alzahrani E, Gomha SM, Zaki ME, Alshehri FF, Al Shehri ZS, Kashtoh H (2025) Macromolecular scaffolds with nitrogen\u2013sulfur motifs: dual \u03b1-glucosidase and urease inhibition with molecular docking and mechanistic evaluation. Int J Biol Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148369","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"951_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-026-00839-w","volume":"40","author":"S Khan","year":"2026","unstructured":"Khan S, Habib MA, Iqbal T, Alzahrani E, Bibi A, Din NU, Ibrahim AB, Kayumov K (2026) Computationally driven discovery of thieno-pyridine thiadiazoles: a synthesis, DFT, docking and dynamics roadmap toward multitarget antidiabetic therapy. J Comput Aided Mol Des 40(1):135","journal-title":"J Comput Aided Mol Des"},{"issue":"21","key":"951_CR46","doi-asserted-by":"publisher","first-page":"30258","DOI":"10.1021\/acsomega.6c00103","volume":"11","author":"PK Panda","year":"2026","unstructured":"Panda PK, Mal S, Mahapatra M, Ghose A, Paidesetty SK (2026) The state of imidazolone as an evolving pharmacophore: current progress and clinical significance in oncology and AMR. ACS Omega 11(21):30258\u201330274","journal-title":"ACS Omega"},{"issue":"1327","key":"951_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.141211","volume":"15","author":"H Khan","year":"2025","unstructured":"Khan H, Jan F, Ullah Q, AlAsmari AF, Alasmari F, Khan A, Ullah S, Alam A, Al-Harrasi A, Khan M, Ali S (2025) Exploring 1, 3, 4-Oxadiazole derivatives of 3, 4-Dihydroxyphenylacetic acid as potent \u03b1-glucosidase inhibitors: Synthesis, structure-activity relationship, molecular docking, and DFT studies. J Mol Struct 15(1327):141211","journal-title":"J Mol Struct"},{"issue":"1","key":"951_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202401914","volume":"10","author":"M Zahir","year":"2025","unstructured":"Zahir M, Alam A, Jan F, Khan A, Alasmari AF, Alasmari F, Khan M, Al\u2010Harrasi A (2025) Synthesis and multi\u2010target inhibition of bis\u2010Schiff bases of barbituric acid: in vitro \u03b1\u2010glucosidase, \u03b1\u2010amylase inhibitory activities with docking and DFT studies. ChemistrySelect 10(1):e202401914","journal-title":"ChemistrySelect"},{"issue":"08","key":"951_CR49","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1142\/S2737416525500899","volume":"25","author":"A Alam","year":"2026","unstructured":"Alam A, Rafiq H, Ismail M, Ahmad I, Assad M, Abbas M, Alanazi MM, Alanazi AS, Kamal M, Elhenawy AA, Khan M (2026) Exploring the \u03b1-amylase, \u03b1-glucosidase inhibition of acyl hydrazone derivatives: in vitro, molecular docking, dynamics simulation, ADMET and DFT studies. J Comput Biophys Chem 25(08):1177\u20131201","journal-title":"J Comput Biophys Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00951-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:02:52Z","timestamp":1791478972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00951-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00951-x","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"26 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"It is declared that there is no conflict of interest between the authors of the current manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"252"}}